Luis Eduardo L. C.
- Country
- Spain
- Department
- Clinical Unit of Infectious Diseases, Clinical Microbiology and Preventive Medicine
Research Overview
- Evaluation of Dolutegravir/Lamivudine and Cabotegravir/Rilpivirine for Virologic Suppression in Antiretroviral-Naive HIV-1 Infected Adults
- Efficacy and Safety of 7 vs 14 Days of Antibiotic Therapy with Meropenem, Aztreonam, and Levofloxacin in Pseudomonas aeruginosa Bacteremia
- Phase 3 Randomized Study of Echinocandin Followed by Ibrexafungerp vs. Echinocandin Followed by Fluconazole in Invasive Candidiasis/Candidemia
Data & Insights
Has run more than one trial at 25 of 78 partner sites.
Specializations
Fungal Infections
Specializes in treating invasive candidiasis and candidemia, exploring innovative therapeutic approaches using echinocandins and new antifungal agents.
- Systemic Fungal Infections
- Antifungal Therapy Management
Investigates oral and intravenous treatment options for severe fungal infections.
Bacterial Infections
Focuses on optimizing treatment durations for Pseudomonas aeruginosa bacteremia and enterococcal infections, including specialized approaches for Enterococcus faecalis endocarditis.
- Bacteremia Management
- Antibiotic Treatment Optimization
- Endocarditis Treatment
Studies antibiotic duration strategies to enhance treatment effectiveness while minimizing exposure.
HIV Treatment
Conducts research on HIV-1 infection treatment modalities, investigating both oral daily regimens and long-acting injectable therapies.
- Antiretroviral Therapy
- Long-acting HIV Treatments
- Treatment-naive Patient Care
Evaluates innovative treatment approaches for previously untreated HIV patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.